Clinic Directory — coming soon. Are you an Australian peptide clinic?Apply to be listed →
Independent · Australian · Education only — not medical adviceAboutEditorial standardsHow we review
HomeEncyclopediaDesmopressin (DDAVP)

Desmopressin (DDAVP)

Vasopressin analogue

Prescription medicine

What it is

A synthetic analogue of the hormone vasopressin, used to reduce urine production.

What the evidence shows

Well-established evidence for its registered indications, where it has been used clinically for decades.

Safety & reported risks

Used under medical supervision; a key risk is low blood sodium (hyponatraemia) from fluid retention, which is why fluid intake is managed and monitored.

Status in Australia

A registered prescription medicine in Australia for defined indications such as diabetes insipidus, bed-wetting and nocturia.

How it’s lawfully accessed

Prescription-only, supplied through a doctor and pharmacy for an approved indication.

Related peptides

OxytocinEndogenous peptide hormonePrescription medicineGlucagonPancreatic peptide hormonePrescription medicine

Sources & further reading

This entry is general information about Desmopressin (DDAVP), not a recommendation to use it. We don’t provide dosing, protocols or sourcing. Speak to a registered practitioner.

Written by The Peptides.au editorial team
Editorial review Checked against current TGA, ARTG and AHPRA public guidance
Last updated 1 June 2026

This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.